Skip to main content

Clinical Documentation for Risk Adjusted Contracts in a changing Environment


Overview
This session with explain the Medicare Advantage Program of Risk Adjustment and how ICD-10 codes map to HCC Categories. We will discuss Types of Risk Adjustment Models, HCC Concepts and how HCC works. Documentation requirements will be explained, as well as qualifying Provider Types and appropriate sources for documentation.
Objectives include an explanation of the history of HCC Coding, how it works, calculation of RAF Scores, Coding & financial impact.
Examples of HCC Categories and the ICD-10 codes mapping to them will be illustrated with a sample note. The speaker will review risks by pointing out Common Coding and Documentation Errors found during RADV Audits. The attendees will receive coding and documentation tips to improve their RAF scores.
Why should you attend this webinar?
To learn about future reimbursement models and improve risk adjustment bonus scores.
Areas Covered in the Session:
Topics which will be covered in the session (bulleted point)
  •  Background of HCC Coding 
  •  How Dignosis Codes link to HCC categories
  •  How HCC categories affect a patient's Risk Score
  •  RADV Audits and Common Errors
Who can Benefit:
Physician Leaders, Financial officers, coders and billers.
Compliance Key INC
717-208-8666

Comments

Popular posts from this blog

The 5 most Dangerous Risks Under New HIPAA Laws

Compliance Key  -   Online hipaa training for employees in US Overview This 90-minute webinar will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits occur. It will also address major changes under the Omnibus Rule and any other applicable updates for 2018. We will go into detail about the 5 biggest "gotcha's" related to compliance with this enigmatic law. I will also speak of multiple litigated cases I have been involved with involving HIPAA compliance (or lack there of areas also covered will be texting, email, encryption, medical messaging, voice data and risk factors as they relate to IT.  The primary goal is to ensure everyone is well educated on what is myth and what is reality with this law, there is so much misleading information regarding the do's and don'ts with HIPAA - I want to add clarity for compliance officers and what you guys need to do and how to best im...

Strategies for Becoming a Business Partner to Your Healthcare Leaders.Compliance Key INC -

Compliance Key INC  -  Healthcare Training Online                                                    Jay Anstine Mr. Anstine's professional background includes working on the provider and the payer side of the market, for large for-profit and non-profit health systems, and small physician-owned entities. In tackling the countless regulatory and operational issues for these diverse organization types, he has developed a deep understanding of the business of healthcare and the regulations that govern the industry.  Webinar Id:  LSHCSJA022  10:00 AM PT | 01:00 PM ET  12/13/2017  Duration 60 mins  Overview All too often compliance is seen as an obstacle or otherwise viewed negatively by healthcare leaders. This presentation will discuss strategies and insights to help the compliance of...

CMO Supplier Quality Agreements :- How to Comply with new FDA and EU Guidelines for Contract Drug Manufacturer

Compliance Key INC  -  Compliance Online Training                                             Roger Cowan Roger Cowan is the Keynote Spaker at Compliance Key Inc. He is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years experience in pharmaceutical quality assurance and manufacturing.  Webinar Id:  LSHCRC007  10:00 AM PT | 01:00 PM ET  12/07/2017  Duration 60 mins Overview A Quality Agreement is a contract between a pharmaceutical firm and a GMP Contract Manufacturer detailing the responsibilities of each party in assuring the quality, safety, and efficacy of the manufactured drug.  Recently, the EU and the FDA issued regulatory guidance to bring some clarity and consistenc...